OrthoPediatrics Corp (KIDS)
31.92
+0.88
(+2.84%)
USD |
NASDAQ |
May 02, 16:00
31.84
-0.08
(-0.25%)
After-Hours: 20:00
OrthoPediatrics Enterprise Value: 689.01M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 02, 2024 | 689.01M |
May 01, 2024 | 668.08M |
April 30, 2024 | 634.54M |
April 29, 2024 | 625.02M |
April 26, 2024 | 649.52M |
April 25, 2024 | 641.91M |
April 24, 2024 | 671.88M |
April 23, 2024 | 658.33M |
April 22, 2024 | 648.10M |
April 19, 2024 | 650.71M |
April 18, 2024 | 630.50M |
April 17, 2024 | 640.96M |
April 16, 2024 | 647.62M |
April 15, 2024 | 654.04M |
April 12, 2024 | 669.27M |
April 11, 2024 | 680.45M |
April 10, 2024 | 685.44M |
April 09, 2024 | 652.85M |
April 08, 2024 | 592.91M |
April 05, 2024 | 583.16M |
April 04, 2024 | 569.36M |
April 03, 2024 | 574.77M |
April 02, 2024 | 558.05M |
April 01, 2024 | 593.61M |
March 28, 2024 | 616.46M |
Date | Value |
---|---|
March 27, 2024 | 611.98M |
March 26, 2024 | 549.11M |
March 25, 2024 | 546.99M |
March 22, 2024 | 536.15M |
March 21, 2024 | 553.82M |
March 20, 2024 | 578.54M |
March 19, 2024 | 556.41M |
March 18, 2024 | 518.49M |
March 15, 2024 | 518.26M |
March 14, 2024 | 531.44M |
March 13, 2024 | 563.71M |
March 12, 2024 | 575.25M |
March 11, 2024 | 583.49M |
March 08, 2024 | 582.08M |
March 07, 2024 | 606.33M |
March 06, 2024 | 564.18M |
March 05, 2024 | 571.48M |
March 04, 2024 | 581.60M |
March 01, 2024 | 590.79M |
February 29, 2024 | 571.08M |
February 28, 2024 | 570.62M |
February 27, 2024 | 592.10M |
February 26, 2024 | 609.15M |
February 23, 2024 | 590.70M |
February 22, 2024 | 591.64M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
464.79M
Minimum
Oct 27 2023
1.379B
Maximum
Nov 05 2021
834.82M
Average
828.27M
Median
Sep 03 2020
Enterprise Value Benchmarks
Paragon 28 Inc | 844.12M |
Anika Therapeutics Inc | 336.25M |
The Cooper Companies Inc | 20.48B |
Staar Surgical Co | 2.003B |
NexGel Inc | 12.49M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -6.691M |
Revenue (Quarterly) | 37.61M |
Total Expenses (Quarterly) | 45.68M |
EPS Diluted (Quarterly) | -0.29 |
Gross Profit Margin (Quarterly) | 71.02% |
Profit Margin (Quarterly) | -17.79% |
Earnings Yield | -2.88% |
Normalized Earnings Yield | -3.141 |